Project Description

vertiflex

CEO: Earl Fender

Sector: Medtech, Orthopaedics
Location: California, USA
Investment Stage: Growth
Investment Status: Acquired by Boston Scientific in 2019
Year Invested: 2017

Vertiflex is a privately held medical device company dedicated to the advancement of minimally invasive solutions for the treatment of lumbar spinal stenosis, which is the leading cause of spinal surgery in the elderly. Founded in 2005 and headquartered in Carlsbad, California, Vertiflex has developed a proprietary, minimally invasive technology for performing indirect decompressions of the lumbar spine. The procedure fills a gap in the stenosis treatment continuum. To date, Vertiflex has compiled the largest, most rigorous body of device clinical evidence related to lumbar spinal stenosis. Superion is an indirect decompression device for the treatment of moderate LSS. Superion prevents compression of the nerves and vasculature in the spine while walking and standing, when symptoms most commonly manifest, and does not require the removal of any bone or tissue to implant.  Superion received approval from the FDA through a Premarket Approval process based on the largest, most extensive body of device clinical evidence related to LSS.

See Vertiflex Group related news here

Back to all companies

Endeavour Vision
Board Member

Alexander Schmitz

Alex Schmitz

Endeavour Vision
Deal Team

Damien Tappy

Damien Tappy